Olink APAC User Group Meeting: The Era of Next Generation

The Olink user group meeting will focus on the Era of Next Generation Proteomics and how portfolio of Olink offerings including our newly launched Olink® Explore 3072 panels and Olink® Signature Q100 instrument have enabled rapid advancements in understanding of human biology and drug discovery. Please register to attend this meeting in order to have a unique opportunity to listen to keynote speakers from leading scientist in the field of proteomics and multi-omics and discuss the latest research methods and findings in understanding complex diseases with the experts in the field.

Date: November 17 at 2:00 PM Beijing Time

Location: Virtual

Speaker and Presentation Details Below

Hisatake Matsumoto, MD, PhD
Assistant Professor, Department of Traumatology and Acute Critical Medicine @Osaka University Graduate School of Medicine, Japan
Session Title: Combination of clinically significant proteins in plasma defines phenotype and combined biomarker associated with prognosis in critical COVID19 patients : Analysis using Olink PEA technology

Calvin Chin, PhD
Associate Professor, Senior Consultant, Clinician Scientist and the Director of the Cardiovascular Magnetic Resonance @(CMR) Center at the National Heart Centre Singapore
Session Title: Diabetes Mellitus is Associated with Accelerated Adverse Cardiac Remodeling in Patients with Hypertension: the REMODEL Study

Philippa Pettingill
Director, Field Application Scientist @Olink
Session Title: Expanded Possibilities with Olink Explore and Signature Q100
photo of Anthony Beckhouse

Anthony Beckhouse
Sr Regional Segment Marketing Manager, Platforms, Asia Pacific and Japan @Illumina
Session Title: Illumina innovations supporting multiomics research

2947

Biomarker assays

~475 million

Protein data points generated

662

Publications listed on website

35

Certified Core Labs

Contact us!